ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,823 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesManagement ConsultingLiestalK30 Ventures AG
K30 Ventures AG Logo
Verified· 2 sources

K30 Ventures AG

Summary

About the company

The core activity of HEMEX AG is to support European biotech and medtech companies in the clinical development of products, with the aim of bringing them to market as quickly as possible. To this end, the company offers a comprehensive service package that includes clinical operations, quality management, regulatory consulting, grant writing services and fundraising.

AI-generated
Offering

Products & services

Industry:Management ConsultingResearch & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Private Equity & Venture Capital
✓ Offered6
Clinical Trials and CRO Services
Clinical trials and CRO services for pharma, biotech, medtech and IVD; study start-up, monitoring, study management, regulatory submissions, pharmacovigilance, medical writing and biostatistics.
Data Protection Advisory for Healthcare
Data protection and DPO solution for healthcare organisations in pharma, biotech, medtech and IVD; DPO setup, compliance oversight, audits, risk assessments, authority liaison and documentation support.
Grant and Non-dilutive Funding Services
Search and application support for non-dilutive funding for healthcare startups; program selection by TRL, grant writing, work packages, consortium partner and subcontractor roles, and access to EU funds.
First-in-Human and PK/PD Studies
First-in-human, Phase I and bioavailability/bioequivalence studies with PK/PD focus; study facilities for early clinical development and related study infrastructure.
Site and Patient Recruitment
Study setup, site feasibility and in-house database management for rapid patient recruitment; support for Phase I–IV trials, PK/PD studies and investigator-initiated studies.
Comparisons

K30 Ventures AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank K30 Ventures AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of K30 Ventures AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Kasernenstrasse 30
4410 Liestal

At a glance

Legal form
Corporation
UID
CHE-464.265.313
Founded
2015 · 11 years
Last commercial register change
March 9, 2026
Employees
11 to 20

Knowledge

No knowledge articles yet

Once K30 Ventures AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

TA
témoc AG
Liestal
IG
intilaris GmbH
Binningen
AA
Ashfield-sellxpert AG
Birsfelden
HG
Hesyra-Medical GmbH
Binningen
IV
Ignited Vision by Susanne Gruber
Sissach
CD
concept-house.ch Daniel Goepfert
Pfeffingen
AA
aviva ag
Münchenstein
NA
Novosolaris AG
Sissach